Michael Lowinger

Follow

Person

Jersey City, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Solid dosage formulations of an orexin receptor antagonist
- Patent number 11,980,623
- Issue date May 14, 2024
- Merck Sharp & Dohme LLC
- Paul A. Harmon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polymer formulations of CETP inhibitors
- Patent number 8,030,359
- Issue date Oct 4, 2011
- Merck Sharp & Dohme Corp.
- Sarah Geers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SOLID DOSAGE FORMULATIONS OF AN OREXIN RECEPTOR ANTAGONIST
- Publication number 20240261299
- Publication date Aug 8, 2024
- Merck Sharp & Dohme LLC
- Paul A. Harmon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITION OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR
- Publication number 20160287568
- Publication date Oct 6, 2016
- MERCK SHARP & DOHME CORP.
- Michael Lowinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Polymer Formulations of CETP Inhibitors
- Publication number 20100227903
- Publication date Sep 9, 2010
- Merck & Co., Inc.
- Sarah Geers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE